Breeze Meds vs Curex
Two GLP-1 desks, one scoreboard. We put Breeze Meds and Curex head-to-head on the published Brief Score — the same six factors, scored the same way.
Curex
FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.
The verdict
Curex takes this head-to-head.
Curex scores 86 to 76 on our six-factor Brief Score — Identical $199 pricing on both molecules, an oral route, LegitScript-certified and nationwide.
That doesn't make Breeze Meds a bad call — it's best for readers starting at a low dose who want nothing charged until a provider has approved them. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Breeze Meds | Curex | |
|---|---|---|
| Brief Score | 76/100 (C) | 86/100 (B) |
| Semaglutide | $199/mo injectable (list $249) · $299/mo oral — the 3- and 6-month bundles cost MORE per month ($249 and $208); only the 12-month prepay is lower, at $191.50 ($2,298) | $199/mo |
| Tirzepatide | $299/mo injectable (list $399) · $399/mo oral — the 3- and 6-month bundles cost MORE per month ($356 and $320); the 12-month prepay is $291.50 ($3,498) | $199/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
| On the tracker | Stableprice stable | Stableprice stable |
Breeze Meds: Every published figure is quoted at the LOWEST dose — the funnel says higher doses may cost more, so these are floors.
Curex: Flat $199 on both molecules; LegitScript-certified and nationwide.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.